ATOS Atossa Therapeutics Inc

$ATOS Looking forward to the SABCS abstract title release on October 30. Hoping to see at least one of the following: • I-SPY 2 combination therapy data • KARISMA 24-month durability data • Preliminary EVANGELINE data

$ATOS Looks like SABCS in December is just the beginning. Maybe we get the I-SPY2 combo data at AACR in April, EVANGELINE at ASCO in June, and then a partnership or buyout? 👀 Just my guess, but the timing makes sense.

$ATOS Quay and bod have played us a long time. Looks like we may be ensuring the dr a lucrative retirement. What nice people we are!

$ATOS Anyone notice how many shares were returned today? That's the most I've ever seen. Pre Split that's 4.5m shares returned so far today.

$ATOS The SABCS abstract titles will be released on October 30, followed by ATOS’s Q3 earnings around November 11–12. Hopefully, we’ll get some meaningful updates around either of these dates.

$ATOS where's is the vol? Is Quay joining the WH as consultant to newly created women's health task force under NIH?

$ATOS Per AH activity, tomorrow may be another bloodbath. Hope it turns around! Everything appears to be trading lower. Rum performing better ah than many others.

$ATOS 17 years, zero approved products, zero revenue. But hey, the CEO sat on an aging panel at Harvard (next to Novo Nordisk!). New carrot, same stick: the "diseases of aging" narrative aimed squarely at retired money. Widows and orphans doesn't mean safe, folks.

$ATOS sold at 70% loss, need to invest somewhere else. This is a sinking ship 🚢. Quay should be getting ready for another 10 to 1 split. Good luck to you all!

$ATOS chances for quay to get any sort of jobs within admin. .now zero. Hope he focuses on the company as a CEO

$ATOS HEISEL WOULD SOMETHING STUPID be doing another offering soon ,before data comes out??

$ATOS and if quay does something stupid and annhilates his stock again, Then yes, of course I will. But im going off the stock pattern, not the company pattern, and based on long calls, Its looking bullish.

$ATOS what possesses u u to now talk 5.00 . u got some hannibal in u .lol; first lets see if your 3 dollar calls expire worthless again tomm.3.10 today for a few moments did nothing for your 3 dollar calls expiring tomm

$ATOS why it’s up: People have digested the PR on the CVR and found it to be positive. Long term holders are buying more and new buyers are starting positions to hold shares before the 19th to be eligible for the bonus.

$ATOS It’s disappointing that we didn’t see the more important I-SPY 2 data: * Z-Endoxifen 40mg monotherapy * Z-Endoxifen + Verzenio (Abemaciclib) combination therapy On the positive side: The data could be strong, and the company may be engaged in discussions with potential partners. On the negative side: The results may be underwhelming, leading to delays in disclosure. Or simply: The data analysis may not be complete yet. For now, we can only speculate. Hopefully, we’ll get some clarity soon.

$ATOS Are these the only two ATOS-related abstracts at SABCS 2026, or am I missing something?🤔

$ATOS big news drop like any day now. Theyre violently shaking people out for something. Calls arent going down.

$ATOS held down for OpEx to let $3 calls expire worthless (thank you I’ll keep my $4K premium + shares) and it’s confirmed with large volume AH. All for shareholders to get in before Monday EOD to be considered for the CVR upon voucher sale. Great move by the company, big plus for long term holders who I would hope have been averaging down along the way. With data around the corner as well, things could shake up quite nicely here.

$ATOS qweek in review .oct 30 2026 pps 2.17 or 14c pre rs. Rightest person here as usual DCAJ PROPS TO DCAJ

$ATOS getting really silly. Shorted a few more. What exactly is bullish? They have a few dollars but will need many many dollars in order to get to FDA approval. Still months away from getting any news on trials. Stay in reality land. No guarantees that the data will be even good.